Narcolepsy Treatment Guidelines

Medication Options

The American Academy of Sleep Medicine recommends modafinil as first-line therapy for narcolepsy, with clinically significant improvements in excessive daytime sleepiness, disease severity, and quality of life 2, 3
The American Academy of Sleep Medicine strongly recommends pitolisant for narcolepsy treatment, showing improvements in both excessive daytime sleepiness and cataplexy 2, 3
The American Academy of Sleep Medicine strongly recommends sodium oxybate, particularly effective for both excessive daytime sleepiness and cataplexy 2, 3
The American Academy of Sleep Medicine strongly recommends solriamfetol for narcolepsy treatment 3
Dextroamphetamine is suggested for narcolepsy treatment with a conditional recommendation 1
Methylphenidate is suggested for narcolepsy treatment with a conditional recommendation 1

Dextroamphetamine is more potent for treating excessive daytime sleepiness in narcolepsy patients 1
Studies have demonstrated clinically significant improvements in both excessive daytime sleepiness and cataplexy with dextroamphetamine 1
Common side effects of dextroamphetamine include sweatiness, edginess, irritability, loss of appetite, and weight gain 1
Dextroamphetamine is a schedule II controlled substance with potential for dependence 1
The American Academy of Sleep Medicine does not recommend dextroamphetamine during pregnancy or breastfeeding based on animal data showing potential fetal harm 4

First-line options for narcolepsy treatment include modafinil, pitolisant, sodium oxybate, or solriamfetol based on symptom profile 2, 3
If first-line treatments are ineffective or contraindicated, dextroamphetamine may be considered 1